- Acquire PRL-02, prostate cancer treatment program being developed by Propella Therapeutics -
TOKYO and PITTSBORO, N.C., Nov. 15, 2023 /PRNewswire/ Astellas Pharma Inc. and Propella.
The Japan Bank for International Cooperation signed on September 5 a loan agreement with Astellas US Holding, Inc. , a U.S. subsidiary of Astellas Pharma Inc. , amounting to up to USD500 million ..
For many companies, particularly those in highly regulated industries, the receipt of a civil investigative demand (CID) or subpoena from the government can understandably trigger stress.
For many companies, particularly those in highly regulated industries, the receipt of a civil investigative demand (CID) or subpoena from the government can understandably trigger.
The United States Court of Appeals for the Seventh Circuit, applying Illinois law, has held that a $100 million settlement between the United States government and a pharmaceutical company.